// company-profile

Stoke Therapeutics, Inc.

STOK
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings156Insiders20
// api This Stoke Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares. Buying was led by Burstein Jennifer.

// 90-day insight

Over the last 90 days, Stoke Therapeutics, Inc. insiders bought $0 across 8 transactions with no open-market sales.

  • Most active insider: Ticho Barry with 3 transactions totaling $188K.
  • Largest single sale: $74K by Ticho Barry on May 1, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Stoke Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$2.22B
QoQ change
+12.8%
Reporting period
2026-03-31
#1
RTW INVESTMENTS, LP
CIK 1493215
$183.1M
5.6M shares
#2
Lynx1 Capital Management LP
CIK 1910456
$155.1M
4.8M shares
#3
FMR LLC
CIK 315066
$153.3M
4.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 16, 2026Allan JonathanSTOK
Sale10b5
1,457$29.95$44K
Jun 3, 2026Burstein JenniferSTOK
Award
17,786$0.00$0K
Jun 3, 2026Krainer Adrian R.STOK
Award
17,786$0.00$0K
Jun 3, 2026Harrison Seth LoringSTOK
Award
17,786$0.00$0K
Jun 3, 2026Smith JulieSTOK
Award
17,786$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.